TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Natural Capsules Limited
NATCAPSUQ

Natural Capsules Limited Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 39/100 · Weak See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹169.52

Change

+0.62 (0.37%)

Open

₹169.0

Prev. Close

₹168.9

Day High

₹171.98

Day Low

₹168.75

Volume Analysis

Traded

528

Delivered

19,325

Delivery %

58.71%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (4)

  • •Low return on equity (-9.45%)
  • •Promoter holding is falling
  • •Below-average fundamentals quality score (39/100)
  • •Low operating margin (-0.4%)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹174.64 ₹173.31 ₹171.41 ₹170.08 ₹168.18 ₹166.85 ₹164.95
Fibonacci ₹173.31 ₹172.08 ₹171.31 ₹170.08 ₹168.85 ₹168.08 ₹166.85
Camarilla ₹170.41 ₹170.11 ₹169.82 ₹170.08 ₹169.22 ₹168.93 ₹168.63

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-6.35%

1 Week

+1.41%

1 Month

-17.29%

3 Months

+13.88%

6 Months

+10.35%

1 Year

-37.71%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

-13.94%

Net margin -13.09% × asset turnover 0.44x × equity multiplier 2.42x

Company Overview

Sector

Healthcare

Market Cap

₹176 Cr

ROE

-9.45%

Book Value

₹168.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.

TopFund Analysis

Natural Capsules Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 39/100. The strongest factor is Risk & Volatility (66/100), while Institutional Ownership (10/100) is the weakest area to weigh before deciding. Notably: Low return on equity (-9.45%); promoter holding is falling.

TopFund Score — Fundamentals Quality

39/100 — Weak

Data confidence: 73/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

63

Growth

54

Valuation

50

Cash Flow

29

Corporate Governance

43

Momentum

22

Institutional Ownership

10

Business Quality

18

Risk & Volatility

66

Liquidity

38

From Screener.in

  • +Stock is trading at 1.01 times its book value
  • −Company has low interest coverage ratio.
  • −Company has a low return on equity of -2.06% over last 3 years.
  • −Contingent liabilities of Rs.75.2 Cr.
  • −Company might be capitalizing the interest cost

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Closure of Trading Window 25 Sep 25 Sep
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 09 Sep

Shareholders approved preferential equity issue and warrant allotment at EGM on September 9, 2026.

Shareholder Meeting / Postal Ballot-Outcome of EGM 9 Sep 09 Sep
Announcement under Regulation 30 (LODR)-Newspaper Publication 03 Sep

Newspaper Publication for Completion of dispatch of Corrigendum Notice of Extraordinary General Meeting ("EGM").

Announcement under Regulation 30 (LODR)-Meeting Updates 02 Sep

Corrigendum to 9 Sep 2026 EGM revises preferential issue: 1,12,500 shares and 4,50,000 warrants at ₹178.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 38 38 40 40 39 41 44 45 45 46 38 58 49
Expenses + 32 32 35 36 35 37 40 41 45 47 40 57 48
Operating Profit 6 5 5 4 4 5 4 4 0 -1 -2 1 1
OPM % 15.81% 13.65% 11.81% 10.22% 11.15% 10.92% 9.74% 9.76% 0.71% -1.94% -6.15% 2.28% 2.3%
Other Income + 0 0 1 1 0 0 0 0 0 0 0 1 2
Interest 1 1 1 1 1 2 2 2 3 3 3 3 5
Depreciation 2 2 2 2 2 2 2 2 4 4 4 4 4
Profit before tax 3 2 2 1 1 1 1 1 -6 -8 -9 -5 -6
Tax % 32.34% 27.1% 32.96% 32.17% 21.79% 201.64% 78.43% 41.57% -8.09% -9.09% -21.7% -1.97% -1.54%
Net Profit + 2 2 1 1 1 -1 0 1 -6 -7 -7 -5 -6
EPS in Rs 2 2 1 1 1 -1 0 0 -5 -7 -5 -3 -4
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 55 60 62 80 135 170 155 169 187 191
Expenses + 49 55 56 68 110 135 135 151 188 191
Operating Profit 6 5 5 11 26 35 20 18 -1 -1
OPM % 10.0% 8.0% 9.0% 14.0% 19.0% 21.0% 13.0% 10.0% -0.5% -0.4%
Other Income + 1 1 1 3 1 1 2 1 2 4
Interest 0 1 1 1 2 4 5 7 12 13
Depreciation 4 3 4 4 5 7 9 9 17 17
Profit before tax 2 2 1 9 19 25 8 3 -28 -28
Tax % 34.0% 7.0% 38.0% 24.0% 28.0% 26.0% 31.0% 78.0% -12.0% —
Net Profit + 1 2 1 7 14 18 6 1 -25 -25
EPS in Rs 1 2 1 7 15 20 6 0 -16 -19
Dividend Payout % 56.0% 32.0% 43.0% 9.0% 5.0% 5.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 48 49 49 56 76 114 194 176 165
Borrowings + 0 5 6 10 53 97 109 152 162
Other Liabilities + 19 14 14 27 29 70 64 81 87
Total Liabilities 73 75 76 99 165 290 377 419 424
Fixed Assets + 22 24 24 38 66 97 103 284 274
CWIP 1 2 2 7 20 88 144 0 4
Investments 5 5 6 0 0 0 3 3 3
Other Assets + 45 43 45 54 79 105 127 133 143
Total Assets 73 75 76 99 165 290 377 419 424
Equity Capital 6 6 6 6 7 9 9 10 10

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 5 2 7 13 -1 17 -8 27 11
Cash from Investing Activity + -1 -7 -6 -16 -46 -105 -73 -44 -11
Cash from Financing Activity + -4 4 -1 3 48 87 82 16 -1
Net Cash Flow 0 -1 0 0 1 0 1 -2 0
CFO/OP 97 57 144 134 17 64 -32 162 -1,634
Free Cash Flow 4 -5 2 -11 -47 -88 -79 -18 -1

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 56.57% → 50.92%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 42.13% 42.13% 42.13% 43.25% 48.39% 48.86% 48.8% 48.75% 48.73% 48.74% 48.96% 49.09%
Promoters 56.57% 56.57% 56.57% 56.57% 51.59% 51.13% 51.21% 51.26% 51.26% 51.26% 51.04% 50.92%
DII 1.31% 1.31% 1.31% 0.18% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Natural Capsules Limited (this stock) 176 — 1.01 -9.45%
Bal Pharma Ltd. 175 24.4 2.13 7.87%
Brooks Lab Limited 167 12.7 1.37 22.0%
Parnax Lab Ltd. 149 14.8 1.56 14.4%
Nectar Lifesciences Ltd. 211 — 0.36 -31.3%
Balaxi Pharma Ltd 126 52.0 0.51 0.59%
Alpa Laboratories Ltd 124 30.6 0.67 8.39%

Which Mutual Funds Hold Natural Capsules Limited?

Frequently Asked Questions about Natural Capsules Limited

Community Sentiment

What are other investors saying about Natural Capsules Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.